Paul M. Vanhoutte Distinguished Lectureship in Vascular
Pharmacology
|
 |
|
Deadline for
submission of nominations for the 2010
Paul M. Vanhoutte Distinguished Lectureship in
Vascular Pharmacology
is September 15, 2009 |
|
The Paul M. Vanhoutte Award in Vascular
Pharmacology was established to honor Dr. Vanhoutte’s lifelong
scientific contributions to our better understanding and
appreciation of the importance of endothelial cells and vascular
smooth muscle function in health and disease and for his mentoring
of countless prominent endothelial and vascular biologists and
pharmacologists.
The Paul M. Vanhoutte Award is a biennial award, consisting an
honorarium of $1,000, a custom-designed crystal bowl depicting the
named Lectureship, and up to $2,000 travel expenses including
registration to the annual spring ASPET meeting. A recipient will be
selected and invited to deliver a state-of-the-art lecture on recent
advances in vascular biology and pharmacology at the spring ASPET
meeting (Division’s programming session). The presentation of
his/her research should be of broad interest and contribute to the
growth of the Cardiovascular Pharmacology Division.
There are no restrictions on institutional affiliation, nationality,
or age of the candidate, but the recipient must be a member of the
ASPET. Nominations must be made by a member of the ASPET, and no
member may nominate more than one candidate per year. Final
selection of the recipient will be made by the Award Committee of
the Division for Cardiovascular Pharmacology.
Nominations should consist of not more than five letters from
nominators describing the contributions to vascular biology and
pharmacology of the candidate that make him/her eligible for this
Award and listing of his/her major contributions, together with a
complete curriculum vitae. To ensure consideration, all information
must be submitted electronically to:
Jane
Nelson (jane.nelson@aspet.org),
American Society for Pharmacology and Experimental Therapeutics,
9650 Rockville Pike, Bethesda, MD 20814-3995 no later than
September 15, 2009. |
|